C1QTNF3 and type 2 diabetes mellitus: Detection of Lp‐PLA2, CTRP3, and their combination can effectively improve the diagnostic efficacy of CVD in patients with T2DM, and help to further evaluate the risk of CVD in T2DM patients and predict the high‐risk population of CVD with T2DM.